Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $6.90 million. The enterprise value is $4.22 million.
Important Dates
The next estimated earnings date is Tuesday, January 13, 2026, after market close.
| Earnings Date | Jan 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 2.95 million shares outstanding. The number of shares has increased by 15.58% in one year.
| Current Share Class | 2.95M |
| Shares Outstanding | 2.95M |
| Shares Change (YoY) | +15.58% |
| Shares Change (QoQ) | +19.57% |
| Owned by Insiders (%) | 10.02% |
| Owned by Institutions (%) | 3.01% |
| Float | 2.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| Forward PS | n/a |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.48 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.61% and return on invested capital (ROIC) is -52.75%.
| Return on Equity (ROE) | -69.61% |
| Return on Assets (ROA) | -41.49% |
| Return on Invested Capital (ROIC) | -52.75% |
| Return on Capital Employed (ROCE) | -94.69% |
| Revenue Per Employee | $90,444 |
| Profits Per Employee | -$67,685 |
| Employee Count | 54 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.37% in the last 52 weeks. The beta is 0.06, so Biomerica's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -21.37% |
| 50-Day Moving Average | 2.65 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 43.40 |
| Average Volume (20 Days) | 16,759 |
Short Selling Information
The latest short interest is 40,058, so 1.36% of the outstanding shares have been sold short.
| Short Interest | 40,058 |
| Short Previous Month | 34,695 |
| Short % of Shares Out | 1.36% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
In the last 12 months, Biomerica had revenue of $4.88 million and -$3.66 million in losses. Loss per share was -$1.50.
| Revenue | 4.88M |
| Gross Profit | 633,000 |
| Operating Income | -4.89M |
| Pretax Income | -3.66M |
| Net Income | -3.66M |
| EBITDA | -4.80M |
| EBIT | -4.89M |
| Loss Per Share | -$1.50 |
Full Income StatementBalance Sheet
The company has $3.05 million in cash and $373,000 in debt, giving a net cash position of $2.68 million or $0.91 per share.
| Cash & Cash Equivalents | 3.05M |
| Total Debt | 373,000 |
| Net Cash | 2.68M |
| Net Cash Per Share | $0.91 |
| Equity (Book Value) | 5.16M |
| Book Value Per Share | 1.83 |
| Working Capital | 4.21M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.77M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.77M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
Gross margin is 12.96%, with operating and profit margins of -100.06% and -74.84%.
| Gross Margin | 12.96% |
| Operating Margin | -100.06% |
| Pretax Margin | -74.84% |
| Profit Margin | -74.84% |
| EBITDA Margin | -98.30% |
| EBIT Margin | -100.06% |
| FCF Margin | n/a |